Janu Putra Sejahtera Tbk. vs Merck Tbk. — how do they compare? Janu Putra Sejahtera Tbk. trades at Rp354 (market cap 1.4T, 42.11M 24h volume), while Merck Tbk. trades at Rp3,740 (market cap 1.68T, 22.8K 24h volume). The key difference: Merck Tbk. is the larger of the two by market cap, and Janu Putra Sejahtera Tbk. is more actively traded (42.11M versus 22.8K). Which is the better fit depends on your goals.
| AYAM | MERK | |
|---|---|---|
Market Cap | 1.4T | 1.68T |
Volume | 42.11M | 22.8K |
Lot | 421.13K | 228 |
Turnover | 14.97B | 82.9M |
Average Price | 355.37 | 3,636.14 |
Value | 14.97B | 82.9M |
Indicative Equilibrium Price | 354 | 3,520 |
Indicative Equilibrium Volume | 734 | 60 |
Trailing returns across standard periods
Latest headlines on both assets
PT Janu Putra Sejahtera Tbk (the Entity) was established based on the Notarial Deed of Endang Sumarningsih, S.H., M.Kn., No. 7, dated December 27, 2007. The Entity started its commercial operations on 2007. The controlling party for the Company is H. Singgih Januratmoko.
Read more on AYAM →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →